Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 448, 14 (5 July 2007) | doi:10.1038/448014a; Published online 4 July 2007
Abbott's AIDS fight-back
Top of page
Abstract
Most drug companies have tried to avoid making enemies of AIDS activist groups. But Abbott Laboratories' patience has snapped, as Erika Check reports.
Early on in the war against AIDS, the drug industry learned that it was expedient to make nice with both developing-world governments and activist groups. But in an increasingly bitter dispute over access to one of its drugs in Thailand, Abbott Laboratories has taken a more aggressive approach.
To read this story in full you will need to login or make a payment (see right).